{ "@graph": [    { "@id": "http://linked.opendata.cz/resource/ATC/L",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/ATCConcept" ] ,      "http://purl.org/dc/terms/title" : [ { "@value" : "Cytostatika a imunomodula\u010Dn\u00ED l\u00E9\u010Diva" , "@language" : "cs" } ,        { "@value" : "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS" , "@language" : "en" } ] ,      "http://www.w3.org/2004/02/skos/core#notation" : [ { "@value" : "L" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ATC/L02",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/ATCConcept" ] ,      "http://purl.org/dc/terms/title" : [ { "@value" : "ENDOCRINE THERAPY" , "@language" : "en" } ,        { "@value" : "Hormon\u00E1ln\u00ED l\u00E9\u010Diva pou\u017E\u00EDvan\u00E1 v onkologii" , "@language" : "cs" } ] ,      "http://www.w3.org/2004/02/skos/core#notation" : [ { "@value" : "L02" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ATC/L02B",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/ATCConcept" ] ,      "http://purl.org/dc/terms/title" : [ { "@value" : "Antagonist\u00E9 hormon\u016F a p\u0159\u00EDbuzn\u00E1 l\u00E9\u010Diva" , "@language" : "cs" } ,        { "@value" : "HORMONE ANTAGONISTS AND RELATED AGENTS" , "@language" : "en" } ] ,      "http://www.w3.org/2004/02/skos/core#notation" : [ { "@value" : "L02B" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ATC/L02BG",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/ATCConcept" ] ,      "http://purl.org/dc/terms/title" : [ { "@value" : "Enzymov\u00E9 inhibitory" , "@language" : "cs" } ,        { "@value" : "Enzyme inhibitors" , "@language" : "en" } ] ,      "http://www.w3.org/2004/02/skos/core#notation" : [ { "@value" : "L02BG" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ATC/L02BG04",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/ATCConcept" ] ,      "http://www.w3.org/2004/02/skos/core#broaderTransitive" : [ "http://linked.opendata.cz/resource/ATC/L" ,        "http://linked.opendata.cz/resource/ATC/L02" ,        "http://linked.opendata.cz/resource/ATC/L02B" ,        "http://linked.opendata.cz/resource/ATC/L02BG" ] ,      "http://purl.org/dc/terms/title" : [ { "@value" : "Letrozol" , "@language" : "cs" } ,        { "@value" : "Letrozole" , "@language" : "en" } ] ,      "http://www.w3.org/2004/02/skos/core#notation" : [ { "@value" : "L02BG04" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ndfrt/disease/N0000000999",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/DiseaseOrFinding" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "Drug hypersensitivity" , "@language" : "en" } ,        { "@value" : "L\u00E9kov\u00E1 alergie" , "@language" : "cs" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ndfrt/disease/N0000010195",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/DiseaseOrFinding" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "T\u011Bhotenstv\u00ED" , "@language" : "cs" } ,        { "@value" : "Pregnancy" , "@language" : "en" } ] } ,    { "@id": "http://linked.opendata.cz/resource/drug-encyclopedia/ingredient/M0184835",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/Ingredient" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "Letrozole" , "@language" : "en" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/contraindicatedWith" : [ "http://linked.opendata.cz/resource/ndfrt/disease/N0000010195" ,        "http://linked.opendata.cz/resource/ndfrt/disease/N0000000999" ] } ,    { "@id": "http://linked.opendata.cz/resource/sukl/medicinal-product/LIKARDA-2-5-MG",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/MedicinalProduct" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasActiveIngredient" : [ "http://linked.opendata.cz/resource/drug-encyclopedia/ingredient/M0184835" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "LIKARDA 2,5 MG" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasATCConcept" : [ "http://linked.opendata.cz/resource/ATC/L02BG04" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasMedicinalProductPackaging" : [ "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0188673" ,        "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0188674" ,        "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0188676" ,        "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0188677" ,        "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0188678" ,        "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0188679" ,        "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0188680" ,        "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0188681" ,        "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0188672" ,        "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0188675" ] } ,    { "@id": "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0188672",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/MedicinalProductPackaging" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "LIKARDA 2,5 MG" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasATCConcept" : [ "http://linked.opendata.cz/resource/ATC/L02BG04" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndicationGroup" : [ { "@value" : "CYTOSTATICA" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasSPCDocument" : [ "http://linked.opendata.cz/resource/sukl/spc/document/SPC158957_doc" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPackagingSize" : [ { "@value" : "10" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRouteOfAdministration" : [ { "@value" : "Peror\u00E1ln\u00ED pod\u00E1n\u00ED" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasStrength" : [ { "@value" : "2.5MG" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndication" : [ { "@value" : "Adjuvantn\u00ED l\u00E9\u010Dba \u017Een v postmenopauze s \u010Dasn\u00FDm st\u00E1diem invazivn\u00EDho karcinomu prsu s pozitivn\u00EDmi hormon\u00E1ln\u00EDmi receptory.\nProdlou\u017Een\u00E1 adjuvantn\u00ED l\u00E9\u010Dba invazivn\u00EDho karcinomu prsu s pozitivn\u00EDmi hormon\u00E1ln\u00EDmi receptory u \u017Een v\u00A0postmenopauze, kter\u00E9 prod\u011Blaly p\u0159edchoz\u00ED p\u011Btiletou standardn\u00ED adjuvantn\u00ED l\u00E9\u010Dbu tamoxifenem.\nPrvn\u00ED linie l\u00E9\u010Dby pokro\u010Dil\u00E9ho karcinomu prsu s pozitivn\u00EDmi hormon\u00E1ln\u00EDmi receptory u \u017Een v\u00A0postmenopauze.\nL\u00E9\u010Dba pokro\u010Dil\u00E9ho karcinomu prsu u \u017Een s p\u0159irozenou nebo um\u011Ble vyvolanou menopauzou po relapsu nebo p\u0159i progresi onemocn\u011Bn\u00ED, kter\u00E9 ji\u017E byly l\u00E9\u010Deny antiestrogeny.\nNeoadjuvantn\u00ED l\u00E9\u010Dba \u017Een v postmenopauze s HER-2 negativn\u00EDm karcinomem prsu s pozitivn\u00EDmi hormon\u00E1ln\u00EDmi receptory, kdy nen\u00ED vhodn\u00E1 chemoterapie a nen\u00ED indikovan\u00FD okam\u017Eit\u00FD chirurgick\u00FD z\u00E1krok. Adjuvantn\u00ED l\u00E9\u010Dba \u017Een v postmenopauze s\u00A0\u010Dasn\u00FDm st\u00E1diem karcinomu prsu s\u00A0pozitivn\u00EDmi hormon\u00E1ln\u00EDmi receptory.\n\u00FA\u010Dinnost nebyla prok\u00E1z\u00E1na u pacientek s\u00A0karcinomem prsu s negativn\u00EDmi hormon\u00E1ln\u00EDmi receptory.\n" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRegistrationState" : [ "http://linked.opendata.cz/resource/sukl/registration-state/R" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasTitleSupplement" : [ { "@value" : "POR TBL FLM 10X2.5MG" , "@language" : "cs" } ] } ,    { "@id": "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0188673",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/MedicinalProductPackaging" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "LIKARDA 2,5 MG" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasATCConcept" : [ "http://linked.opendata.cz/resource/ATC/L02BG04" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndicationGroup" : [ { "@value" : "CYTOSTATICA" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasSPCDocument" : [ "http://linked.opendata.cz/resource/sukl/spc/document/SPC158957_doc" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPackagingSize" : [ { "@value" : "14" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRouteOfAdministration" : [ { "@value" : "Peror\u00E1ln\u00ED pod\u00E1n\u00ED" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasStrength" : [ { "@value" : "2.5MG" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndication" : [ { "@value" : "Adjuvantn\u00ED l\u00E9\u010Dba \u017Een v postmenopauze s \u010Dasn\u00FDm st\u00E1diem invazivn\u00EDho karcinomu prsu s pozitivn\u00EDmi hormon\u00E1ln\u00EDmi receptory.\nProdlou\u017Een\u00E1 adjuvantn\u00ED l\u00E9\u010Dba invazivn\u00EDho karcinomu prsu s pozitivn\u00EDmi hormon\u00E1ln\u00EDmi receptory u \u017Een v\u00A0postmenopauze, kter\u00E9 prod\u011Blaly p\u0159edchoz\u00ED p\u011Btiletou standardn\u00ED adjuvantn\u00ED l\u00E9\u010Dbu tamoxifenem.\nPrvn\u00ED linie l\u00E9\u010Dby pokro\u010Dil\u00E9ho karcinomu prsu s pozitivn\u00EDmi hormon\u00E1ln\u00EDmi receptory u \u017Een v\u00A0postmenopauze.\nL\u00E9\u010Dba pokro\u010Dil\u00E9ho karcinomu prsu u \u017Een s p\u0159irozenou nebo um\u011Ble vyvolanou menopauzou po relapsu nebo p\u0159i progresi onemocn\u011Bn\u00ED, kter\u00E9 ji\u017E byly l\u00E9\u010Deny antiestrogeny.\nNeoadjuvantn\u00ED l\u00E9\u010Dba \u017Een v postmenopauze s HER-2 negativn\u00EDm karcinomem prsu s pozitivn\u00EDmi hormon\u00E1ln\u00EDmi receptory, kdy nen\u00ED vhodn\u00E1 chemoterapie a nen\u00ED indikovan\u00FD okam\u017Eit\u00FD chirurgick\u00FD z\u00E1krok. Adjuvantn\u00ED l\u00E9\u010Dba \u017Een v postmenopauze s\u00A0\u010Dasn\u00FDm st\u00E1diem karcinomu prsu s\u00A0pozitivn\u00EDmi hormon\u00E1ln\u00EDmi receptory.\n\u00FA\u010Dinnost nebyla prok\u00E1z\u00E1na u pacientek s\u00A0karcinomem prsu s negativn\u00EDmi hormon\u00E1ln\u00EDmi receptory.\n" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRegistrationState" : [ "http://linked.opendata.cz/resource/sukl/registration-state/R" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasTitleSupplement" : [ { "@value" : "POR TBL FLM 14X2.5MG" , "@language" : "cs" } ] } ,    { "@id": "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0188674",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/MedicinalProductPackaging" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "LIKARDA 2,5 MG" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasATCConcept" : [ "http://linked.opendata.cz/resource/ATC/L02BG04" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndicationGroup" : [ { "@value" : "CYTOSTATICA" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasSPCDocument" : [ "http://linked.opendata.cz/resource/sukl/spc/document/SPC158957_doc" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPackagingSize" : [ { "@value" : "28" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRouteOfAdministration" : [ { "@value" : "Peror\u00E1ln\u00ED pod\u00E1n\u00ED" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasStrength" : [ { "@value" : "2.5MG" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndication" : [ { "@value" : "Adjuvantn\u00ED l\u00E9\u010Dba \u017Een v postmenopauze s \u010Dasn\u00FDm st\u00E1diem invazivn\u00EDho karcinomu prsu s pozitivn\u00EDmi hormon\u00E1ln\u00EDmi receptory.\nProdlou\u017Een\u00E1 adjuvantn\u00ED l\u00E9\u010Dba invazivn\u00EDho karcinomu prsu s pozitivn\u00EDmi hormon\u00E1ln\u00EDmi receptory u \u017Een v\u00A0postmenopauze, kter\u00E9 prod\u011Blaly p\u0159edchoz\u00ED p\u011Btiletou standardn\u00ED adjuvantn\u00ED l\u00E9\u010Dbu tamoxifenem.\nPrvn\u00ED linie l\u00E9\u010Dby pokro\u010Dil\u00E9ho karcinomu prsu s pozitivn\u00EDmi hormon\u00E1ln\u00EDmi receptory u \u017Een v\u00A0postmenopauze.\nL\u00E9\u010Dba pokro\u010Dil\u00E9ho karcinomu prsu u \u017Een s p\u0159irozenou nebo um\u011Ble vyvolanou menopauzou po relapsu nebo p\u0159i progresi onemocn\u011Bn\u00ED, kter\u00E9 ji\u017E byly l\u00E9\u010Deny antiestrogeny.\nNeoadjuvantn\u00ED l\u00E9\u010Dba \u017Een v postmenopauze s HER-2 negativn\u00EDm karcinomem prsu s pozitivn\u00EDmi hormon\u00E1ln\u00EDmi receptory, kdy nen\u00ED vhodn\u00E1 chemoterapie a nen\u00ED indikovan\u00FD okam\u017Eit\u00FD chirurgick\u00FD z\u00E1krok. Adjuvantn\u00ED l\u00E9\u010Dba \u017Een v postmenopauze s\u00A0\u010Dasn\u00FDm st\u00E1diem karcinomu prsu s\u00A0pozitivn\u00EDmi hormon\u00E1ln\u00EDmi receptory.\n\u00FA\u010Dinnost nebyla prok\u00E1z\u00E1na u pacientek s\u00A0karcinomem prsu s negativn\u00EDmi hormon\u00E1ln\u00EDmi receptory.\n" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRegistrationState" : [ "http://linked.opendata.cz/resource/sukl/registration-state/R" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasTitleSupplement" : [ { "@value" : "POR TBL FLM 28X2.5MG" , "@language" : "cs" } ] } ,    { "@id": "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0188676",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/MedicinalProductPackaging" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "LIKARDA 2,5 MG" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasATCConcept" : [ "http://linked.opendata.cz/resource/ATC/L02BG04" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndicationGroup" : [ { "@value" : "CYTOSTATICA" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasSPCDocument" : [ "http://linked.opendata.cz/resource/sukl/spc/document/SPC158957_doc" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPackagingSize" : [ { "@value" : "50" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRouteOfAdministration" : [ { "@value" : "Peror\u00E1ln\u00ED pod\u00E1n\u00ED" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasStrength" : [ { "@value" : "2.5MG" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndication" : [ { "@value" : "Adjuvantn\u00ED l\u00E9\u010Dba \u017Een v postmenopauze s \u010Dasn\u00FDm st\u00E1diem invazivn\u00EDho karcinomu prsu s pozitivn\u00EDmi hormon\u00E1ln\u00EDmi receptory.\nProdlou\u017Een\u00E1 adjuvantn\u00ED l\u00E9\u010Dba invazivn\u00EDho karcinomu prsu s pozitivn\u00EDmi hormon\u00E1ln\u00EDmi receptory u \u017Een v\u00A0postmenopauze, kter\u00E9 prod\u011Blaly p\u0159edchoz\u00ED p\u011Btiletou standardn\u00ED adjuvantn\u00ED l\u00E9\u010Dbu tamoxifenem.\nPrvn\u00ED linie l\u00E9\u010Dby pokro\u010Dil\u00E9ho karcinomu prsu s pozitivn\u00EDmi hormon\u00E1ln\u00EDmi receptory u \u017Een v\u00A0postmenopauze.\nL\u00E9\u010Dba pokro\u010Dil\u00E9ho karcinomu prsu u \u017Een s p\u0159irozenou nebo um\u011Ble vyvolanou menopauzou po relapsu nebo p\u0159i progresi onemocn\u011Bn\u00ED, kter\u00E9 ji\u017E byly l\u00E9\u010Deny antiestrogeny.\nNeoadjuvantn\u00ED l\u00E9\u010Dba \u017Een v postmenopauze s HER-2 negativn\u00EDm karcinomem prsu s pozitivn\u00EDmi hormon\u00E1ln\u00EDmi receptory, kdy nen\u00ED vhodn\u00E1 chemoterapie a nen\u00ED indikovan\u00FD okam\u017Eit\u00FD chirurgick\u00FD z\u00E1krok. Adjuvantn\u00ED l\u00E9\u010Dba \u017Een v postmenopauze s\u00A0\u010Dasn\u00FDm st\u00E1diem karcinomu prsu s\u00A0pozitivn\u00EDmi hormon\u00E1ln\u00EDmi receptory.\n\u00FA\u010Dinnost nebyla prok\u00E1z\u00E1na u pacientek s\u00A0karcinomem prsu s negativn\u00EDmi hormon\u00E1ln\u00EDmi receptory.\n" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRegistrationState" : [ "http://linked.opendata.cz/resource/sukl/registration-state/R" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasTitleSupplement" : [ { "@value" : "POR TBL FLM 50X2.5MG" , "@language" : "cs" } ] } ,    { "@id": "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0188677",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/MedicinalProductPackaging" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "LIKARDA 2,5 MG" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasATCConcept" : [ "http://linked.opendata.cz/resource/ATC/L02BG04" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndicationGroup" : [ { "@value" : "CYTOSTATICA" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasSPCDocument" : [ "http://linked.opendata.cz/resource/sukl/spc/document/SPC158957_doc" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPackagingSize" : [ { "@value" : "60" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRouteOfAdministration" : [ { "@value" : "Peror\u00E1ln\u00ED pod\u00E1n\u00ED" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasStrength" : [ { "@value" : "2.5MG" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndication" : [ { "@value" : "Adjuvantn\u00ED l\u00E9\u010Dba \u017Een v postmenopauze s \u010Dasn\u00FDm st\u00E1diem invazivn\u00EDho karcinomu prsu s pozitivn\u00EDmi hormon\u00E1ln\u00EDmi receptory.\nProdlou\u017Een\u00E1 adjuvantn\u00ED l\u00E9\u010Dba invazivn\u00EDho karcinomu prsu s pozitivn\u00EDmi hormon\u00E1ln\u00EDmi receptory u \u017Een v\u00A0postmenopauze, kter\u00E9 prod\u011Blaly p\u0159edchoz\u00ED p\u011Btiletou standardn\u00ED adjuvantn\u00ED l\u00E9\u010Dbu tamoxifenem.\nPrvn\u00ED linie l\u00E9\u010Dby pokro\u010Dil\u00E9ho karcinomu prsu s pozitivn\u00EDmi hormon\u00E1ln\u00EDmi receptory u \u017Een v\u00A0postmenopauze.\nL\u00E9\u010Dba pokro\u010Dil\u00E9ho karcinomu prsu u \u017Een s p\u0159irozenou nebo um\u011Ble vyvolanou menopauzou po relapsu nebo p\u0159i progresi onemocn\u011Bn\u00ED, kter\u00E9 ji\u017E byly l\u00E9\u010Deny antiestrogeny.\nNeoadjuvantn\u00ED l\u00E9\u010Dba \u017Een v postmenopauze s HER-2 negativn\u00EDm karcinomem prsu s pozitivn\u00EDmi hormon\u00E1ln\u00EDmi receptory, kdy nen\u00ED vhodn\u00E1 chemoterapie a nen\u00ED indikovan\u00FD okam\u017Eit\u00FD chirurgick\u00FD z\u00E1krok. Adjuvantn\u00ED l\u00E9\u010Dba \u017Een v postmenopauze s\u00A0\u010Dasn\u00FDm st\u00E1diem karcinomu prsu s\u00A0pozitivn\u00EDmi hormon\u00E1ln\u00EDmi receptory.\n\u00FA\u010Dinnost nebyla prok\u00E1z\u00E1na u pacientek s\u00A0karcinomem prsu s negativn\u00EDmi hormon\u00E1ln\u00EDmi receptory.\n" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRegistrationState" : [ "http://linked.opendata.cz/resource/sukl/registration-state/R" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasResumedMarketingDate" : [ { "@value" : "2013-06-25" , "@type" : "http://www.w3.org/2001/XMLSchema#date" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasMaximalPrice" : [ { "@value" : 5215.5498046875 , "@type" : "http://www.w3.org/2001/XMLSchema#float" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasReimbursementAmount" : [ { "@value" : 4558.9599609375 , "@type" : "http://www.w3.org/2001/XMLSchema#float" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasTitleSupplement" : [ { "@value" : "POR TBL FLM 60X2.5MG" , "@language" : "cs" } ] } ,    { "@id": "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0188678",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/MedicinalProductPackaging" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "LIKARDA 2,5 MG" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasATCConcept" : [ "http://linked.opendata.cz/resource/ATC/L02BG04" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndicationGroup" : [ { "@value" : "CYTOSTATICA" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasSPCDocument" : [ "http://linked.opendata.cz/resource/sukl/spc/document/SPC158957_doc" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPackagingSize" : [ { "@value" : "84" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRouteOfAdministration" : [ { "@value" : "Peror\u00E1ln\u00ED pod\u00E1n\u00ED" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasStrength" : [ { "@value" : "2.5MG" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndication" : [ { "@value" : "Adjuvantn\u00ED l\u00E9\u010Dba \u017Een v postmenopauze s \u010Dasn\u00FDm st\u00E1diem invazivn\u00EDho karcinomu prsu s pozitivn\u00EDmi hormon\u00E1ln\u00EDmi receptory.\nProdlou\u017Een\u00E1 adjuvantn\u00ED l\u00E9\u010Dba invazivn\u00EDho karcinomu prsu s pozitivn\u00EDmi hormon\u00E1ln\u00EDmi receptory u \u017Een v\u00A0postmenopauze, kter\u00E9 prod\u011Blaly p\u0159edchoz\u00ED p\u011Btiletou standardn\u00ED adjuvantn\u00ED l\u00E9\u010Dbu tamoxifenem.\nPrvn\u00ED linie l\u00E9\u010Dby pokro\u010Dil\u00E9ho karcinomu prsu s pozitivn\u00EDmi hormon\u00E1ln\u00EDmi receptory u \u017Een v\u00A0postmenopauze.\nL\u00E9\u010Dba pokro\u010Dil\u00E9ho karcinomu prsu u \u017Een s p\u0159irozenou nebo um\u011Ble vyvolanou menopauzou po relapsu nebo p\u0159i progresi onemocn\u011Bn\u00ED, kter\u00E9 ji\u017E byly l\u00E9\u010Deny antiestrogeny.\nNeoadjuvantn\u00ED l\u00E9\u010Dba \u017Een v postmenopauze s HER-2 negativn\u00EDm karcinomem prsu s pozitivn\u00EDmi hormon\u00E1ln\u00EDmi receptory, kdy nen\u00ED vhodn\u00E1 chemoterapie a nen\u00ED indikovan\u00FD okam\u017Eit\u00FD chirurgick\u00FD z\u00E1krok. Adjuvantn\u00ED l\u00E9\u010Dba \u017Een v postmenopauze s\u00A0\u010Dasn\u00FDm st\u00E1diem karcinomu prsu s\u00A0pozitivn\u00EDmi hormon\u00E1ln\u00EDmi receptory.\n\u00FA\u010Dinnost nebyla prok\u00E1z\u00E1na u pacientek s\u00A0karcinomem prsu s negativn\u00EDmi hormon\u00E1ln\u00EDmi receptory.\n" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRegistrationState" : [ "http://linked.opendata.cz/resource/sukl/registration-state/R" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasTitleSupplement" : [ { "@value" : "POR TBL FLM 84X2.5MG" , "@language" : "cs" } ] } ,    { "@id": "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0188679",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/MedicinalProductPackaging" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "LIKARDA 2,5 MG" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasATCConcept" : [ "http://linked.opendata.cz/resource/ATC/L02BG04" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndicationGroup" : [ { "@value" : "CYTOSTATICA" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasSPCDocument" : [ "http://linked.opendata.cz/resource/sukl/spc/document/SPC158957_doc" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPackagingSize" : [ { "@value" : "90" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRouteOfAdministration" : [ { "@value" : "Peror\u00E1ln\u00ED pod\u00E1n\u00ED" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasStrength" : [ { "@value" : "2.5MG" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndication" : [ { "@value" : "Adjuvantn\u00ED l\u00E9\u010Dba \u017Een v postmenopauze s \u010Dasn\u00FDm st\u00E1diem invazivn\u00EDho karcinomu prsu s pozitivn\u00EDmi hormon\u00E1ln\u00EDmi receptory.\nProdlou\u017Een\u00E1 adjuvantn\u00ED l\u00E9\u010Dba invazivn\u00EDho karcinomu prsu s pozitivn\u00EDmi hormon\u00E1ln\u00EDmi receptory u \u017Een v\u00A0postmenopauze, kter\u00E9 prod\u011Blaly p\u0159edchoz\u00ED p\u011Btiletou standardn\u00ED adjuvantn\u00ED l\u00E9\u010Dbu tamoxifenem.\nPrvn\u00ED linie l\u00E9\u010Dby pokro\u010Dil\u00E9ho karcinomu prsu s pozitivn\u00EDmi hormon\u00E1ln\u00EDmi receptory u \u017Een v\u00A0postmenopauze.\nL\u00E9\u010Dba pokro\u010Dil\u00E9ho karcinomu prsu u \u017Een s p\u0159irozenou nebo um\u011Ble vyvolanou menopauzou po relapsu nebo p\u0159i progresi onemocn\u011Bn\u00ED, kter\u00E9 ji\u017E byly l\u00E9\u010Deny antiestrogeny.\nNeoadjuvantn\u00ED l\u00E9\u010Dba \u017Een v postmenopauze s HER-2 negativn\u00EDm karcinomem prsu s pozitivn\u00EDmi hormon\u00E1ln\u00EDmi receptory, kdy nen\u00ED vhodn\u00E1 chemoterapie a nen\u00ED indikovan\u00FD okam\u017Eit\u00FD chirurgick\u00FD z\u00E1krok. Adjuvantn\u00ED l\u00E9\u010Dba \u017Een v postmenopauze s\u00A0\u010Dasn\u00FDm st\u00E1diem karcinomu prsu s\u00A0pozitivn\u00EDmi hormon\u00E1ln\u00EDmi receptory.\n\u00FA\u010Dinnost nebyla prok\u00E1z\u00E1na u pacientek s\u00A0karcinomem prsu s negativn\u00EDmi hormon\u00E1ln\u00EDmi receptory.\n" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRegistrationState" : [ "http://linked.opendata.cz/resource/sukl/registration-state/R" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasResumedMarketingDate" : [ { "@value" : "2013-06-25" , "@type" : "http://www.w3.org/2001/XMLSchema#date" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasMaximalPrice" : [ { "@value" : 7767.9501953125 , "@type" : "http://www.w3.org/2001/XMLSchema#float" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasReimbursementAmount" : [ { "@value" : 6838.43994140625 , "@type" : "http://www.w3.org/2001/XMLSchema#float" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasTitleSupplement" : [ { "@value" : "POR TBL FLM 90X2.5MG" , "@language" : "cs" } ] } ,    { "@id": "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0188680",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/MedicinalProductPackaging" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "LIKARDA 2,5 MG" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasATCConcept" : [ "http://linked.opendata.cz/resource/ATC/L02BG04" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndicationGroup" : [ { "@value" : "CYTOSTATICA" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasSPCDocument" : [ "http://linked.opendata.cz/resource/sukl/spc/document/SPC158957_doc" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPackagingSize" : [ { "@value" : "98" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRouteOfAdministration" : [ { "@value" : "Peror\u00E1ln\u00ED pod\u00E1n\u00ED" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasStrength" : [ { "@value" : "2.5MG" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndication" : [ { "@value" : "Adjuvantn\u00ED l\u00E9\u010Dba \u017Een v postmenopauze s \u010Dasn\u00FDm st\u00E1diem invazivn\u00EDho karcinomu prsu s pozitivn\u00EDmi hormon\u00E1ln\u00EDmi receptory.\nProdlou\u017Een\u00E1 adjuvantn\u00ED l\u00E9\u010Dba invazivn\u00EDho karcinomu prsu s pozitivn\u00EDmi hormon\u00E1ln\u00EDmi receptory u \u017Een v\u00A0postmenopauze, kter\u00E9 prod\u011Blaly p\u0159edchoz\u00ED p\u011Btiletou standardn\u00ED adjuvantn\u00ED l\u00E9\u010Dbu tamoxifenem.\nPrvn\u00ED linie l\u00E9\u010Dby pokro\u010Dil\u00E9ho karcinomu prsu s pozitivn\u00EDmi hormon\u00E1ln\u00EDmi receptory u \u017Een v\u00A0postmenopauze.\nL\u00E9\u010Dba pokro\u010Dil\u00E9ho karcinomu prsu u \u017Een s p\u0159irozenou nebo um\u011Ble vyvolanou menopauzou po relapsu nebo p\u0159i progresi onemocn\u011Bn\u00ED, kter\u00E9 ji\u017E byly l\u00E9\u010Deny antiestrogeny.\nNeoadjuvantn\u00ED l\u00E9\u010Dba \u017Een v postmenopauze s HER-2 negativn\u00EDm karcinomem prsu s pozitivn\u00EDmi hormon\u00E1ln\u00EDmi receptory, kdy nen\u00ED vhodn\u00E1 chemoterapie a nen\u00ED indikovan\u00FD okam\u017Eit\u00FD chirurgick\u00FD z\u00E1krok. Adjuvantn\u00ED l\u00E9\u010Dba \u017Een v postmenopauze s\u00A0\u010Dasn\u00FDm st\u00E1diem karcinomu prsu s\u00A0pozitivn\u00EDmi hormon\u00E1ln\u00EDmi receptory.\n\u00FA\u010Dinnost nebyla prok\u00E1z\u00E1na u pacientek s\u00A0karcinomem prsu s negativn\u00EDmi hormon\u00E1ln\u00EDmi receptory.\n" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRegistrationState" : [ "http://linked.opendata.cz/resource/sukl/registration-state/R" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasTitleSupplement" : [ { "@value" : "POR TBL FLM 98X2.5MG" , "@language" : "cs" } ] } ,    { "@id": "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0188681",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/MedicinalProductPackaging" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "LIKARDA 2,5 MG" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasATCConcept" : [ "http://linked.opendata.cz/resource/ATC/L02BG04" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndicationGroup" : [ { "@value" : "CYTOSTATICA" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasSPCDocument" : [ "http://linked.opendata.cz/resource/sukl/spc/document/SPC158957_doc" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPackagingSize" : [ { "@value" : "100" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRouteOfAdministration" : [ { "@value" : "Peror\u00E1ln\u00ED pod\u00E1n\u00ED" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasStrength" : [ { "@value" : "2.5MG" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndication" : [ { "@value" : "Adjuvantn\u00ED l\u00E9\u010Dba \u017Een v postmenopauze s \u010Dasn\u00FDm st\u00E1diem invazivn\u00EDho karcinomu prsu s pozitivn\u00EDmi hormon\u00E1ln\u00EDmi receptory.\nProdlou\u017Een\u00E1 adjuvantn\u00ED l\u00E9\u010Dba invazivn\u00EDho karcinomu prsu s pozitivn\u00EDmi hormon\u00E1ln\u00EDmi receptory u \u017Een v\u00A0postmenopauze, kter\u00E9 prod\u011Blaly p\u0159edchoz\u00ED p\u011Btiletou standardn\u00ED adjuvantn\u00ED l\u00E9\u010Dbu tamoxifenem.\nPrvn\u00ED linie l\u00E9\u010Dby pokro\u010Dil\u00E9ho karcinomu prsu s pozitivn\u00EDmi hormon\u00E1ln\u00EDmi receptory u \u017Een v\u00A0postmenopauze.\nL\u00E9\u010Dba pokro\u010Dil\u00E9ho karcinomu prsu u \u017Een s p\u0159irozenou nebo um\u011Ble vyvolanou menopauzou po relapsu nebo p\u0159i progresi onemocn\u011Bn\u00ED, kter\u00E9 ji\u017E byly l\u00E9\u010Deny antiestrogeny.\nNeoadjuvantn\u00ED l\u00E9\u010Dba \u017Een v postmenopauze s HER-2 negativn\u00EDm karcinomem prsu s pozitivn\u00EDmi hormon\u00E1ln\u00EDmi receptory, kdy nen\u00ED vhodn\u00E1 chemoterapie a nen\u00ED indikovan\u00FD okam\u017Eit\u00FD chirurgick\u00FD z\u00E1krok. Adjuvantn\u00ED l\u00E9\u010Dba \u017Een v postmenopauze s\u00A0\u010Dasn\u00FDm st\u00E1diem karcinomu prsu s\u00A0pozitivn\u00EDmi hormon\u00E1ln\u00EDmi receptory.\n\u00FA\u010Dinnost nebyla prok\u00E1z\u00E1na u pacientek s\u00A0karcinomem prsu s negativn\u00EDmi hormon\u00E1ln\u00EDmi receptory.\n" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRegistrationState" : [ "http://linked.opendata.cz/resource/sukl/registration-state/R" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasTitleSupplement" : [ { "@value" : "POR TBL FLM 100X2.5MG" , "@language" : "cs" } ] } ,    { "@id": "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0188675",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/MedicinalProductPackaging" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "LIKARDA 2,5 MG" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasATCConcept" : [ "http://linked.opendata.cz/resource/ATC/L02BG04" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndicationGroup" : [ { "@value" : "CYTOSTATICA" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasSPCDocument" : [ "http://linked.opendata.cz/resource/sukl/spc/document/SPC158957_doc" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPackagingSize" : [ { "@value" : "30" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRouteOfAdministration" : [ { "@value" : "Peror\u00E1ln\u00ED pod\u00E1n\u00ED" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasStrength" : [ { "@value" : "2.5MG" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndication" : [ { "@value" : "Adjuvantn\u00ED l\u00E9\u010Dba \u017Een v postmenopauze s \u010Dasn\u00FDm st\u00E1diem invazivn\u00EDho karcinomu prsu s pozitivn\u00EDmi hormon\u00E1ln\u00EDmi receptory.\nProdlou\u017Een\u00E1 adjuvantn\u00ED l\u00E9\u010Dba invazivn\u00EDho karcinomu prsu s pozitivn\u00EDmi hormon\u00E1ln\u00EDmi receptory u \u017Een v\u00A0postmenopauze, kter\u00E9 prod\u011Blaly p\u0159edchoz\u00ED p\u011Btiletou standardn\u00ED adjuvantn\u00ED l\u00E9\u010Dbu tamoxifenem.\nPrvn\u00ED linie l\u00E9\u010Dby pokro\u010Dil\u00E9ho karcinomu prsu s pozitivn\u00EDmi hormon\u00E1ln\u00EDmi receptory u \u017Een v\u00A0postmenopauze.\nL\u00E9\u010Dba pokro\u010Dil\u00E9ho karcinomu prsu u \u017Een s p\u0159irozenou nebo um\u011Ble vyvolanou menopauzou po relapsu nebo p\u0159i progresi onemocn\u011Bn\u00ED, kter\u00E9 ji\u017E byly l\u00E9\u010Deny antiestrogeny.\nNeoadjuvantn\u00ED l\u00E9\u010Dba \u017Een v postmenopauze s HER-2 negativn\u00EDm karcinomem prsu s pozitivn\u00EDmi hormon\u00E1ln\u00EDmi receptory, kdy nen\u00ED vhodn\u00E1 chemoterapie a nen\u00ED indikovan\u00FD okam\u017Eit\u00FD chirurgick\u00FD z\u00E1krok. Adjuvantn\u00ED l\u00E9\u010Dba \u017Een v postmenopauze s\u00A0\u010Dasn\u00FDm st\u00E1diem karcinomu prsu s\u00A0pozitivn\u00EDmi hormon\u00E1ln\u00EDmi receptory.\n\u00FA\u010Dinnost nebyla prok\u00E1z\u00E1na u pacientek s\u00A0karcinomem prsu s negativn\u00EDmi hormon\u00E1ln\u00EDmi receptory.\n" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRegistrationState" : [ "http://linked.opendata.cz/resource/sukl/registration-state/R" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasResumedMarketingDate" : [ { "@value" : "2013-06-25" , "@type" : "http://www.w3.org/2001/XMLSchema#date" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasMaximalPrice" : [ { "@value" : 2607.080078125 , "@type" : "http://www.w3.org/2001/XMLSchema#float" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasReimbursementAmount" : [ { "@value" : 2279.47998046875 , "@type" : "http://www.w3.org/2001/XMLSchema#float" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasTitleSupplement" : [ { "@value" : "POR TBL FLM 30X2.5MG" , "@language" : "cs" } ] }] }